Information was received from a consumer via a manufacturer representative (rep) regarding a patient with an implantable neurostimulator (ins).It was reported that the patient was unable to charge the ins.The rep saw the patient on (b)(6) at the healthcare provider (hcp office).The ins was determined to be overdischarged.The patient said he was pain free for about 4 months and didn¿t charge the ins.Then, when the patient¿s pain came back he couldn¿t charge.It was explained to the patient that he needed to charge at least monthly even if the device is not being used.The patient said he forgot to charge.The ins was trickle charged in the office and the patient came back once the ins was charged.A device reset was done, and impedance check revealed impedances over 10,000 on contacts 8, and 10-12.All other contacts were within normal limits.The device was reprogrammed, and the patient was happy with the coverage in the low back and left leg.The issue was reported to be resolved.No further complications were reported.
|